» Articles » PMID: 20869705

Estrogen Regulates Endometrial Cell Cytoskeletal Remodeling and Motility Via Focal Adhesion Kinase

Overview
Journal Fertil Steril
Date 2010 Sep 28
PMID 20869705
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To explore the effects of 17β-estradiol (E(2)) on cytoskeletal remodeling and motility of endometrial stromal cells (ESC) and Ishikawa cells and to characterize the role of focal adhesion kinase (FAK) in these processes.

Design: In vitro study of cytoskeletal remodeling and cellular morphology and motility in ESC or Ishikawa cells.

Setting: University research center.

Patient(s): Endometrial samples obtained from women requiring endometrial biopsies.

Intervention(s): Treatments with E(2) and multiple inhibitors of signaling pathways.

Main Outcome Measure(s): Activation of FAK, actin remodeling, membrane morphology, cell motility, and invasion.

Result(s): Estrogen induces a rapid and concentration-related FAK phosphorylation in ESC and Ishikawa cells. In this time frame, FAK localizes to the plasma membrane at sites of focal adhesion complexes formation, as shown by immunofluorescence. Phosphorylation of FAK in the presence of estrogen depends on the recruitment of both estrogen receptor α and estrogen receptor β and of a rapid G protein-dependent signaling to c-Src and phosphatidylinositol 3-OH kinase. Activation of FAK in ESC and Ishikawa cells is required for estrogen-induced horizontal migration and invasion of three-dimensional matrices of endometrial cells.

Conclusion(s): Estrogen enhances cytoskeletal and membrane remodeling in ESC and Ishikawa cells by controlling FAK, thus resulting in enhanced cell motility and invasion. These findings may have clinical relevance for the development of new therapeutic strategies for the prevention or control of endometrial diseases.

Citing Articles

An Assessment of the Mechanophysical and Hormonal Impact on Human Endometrial Epithelium Mechanics and Receptivity.

Sternberg A, Izmaylova L, Buck V, Classen-Linke I, Leube R Int J Mol Sci. 2024; 25(7).

PMID: 38612536 PMC: 11011295. DOI: 10.3390/ijms25073726.


Roles of estrogen receptor α in endometrial carcinoma (Review).

Ge Y, Ni X, Li J, Ye M, Jin X Oncol Lett. 2023; 26(6):530.

PMID: 38020303 PMC: 10644365. DOI: 10.3892/ol.2023.14117.


17β-Estradiol Mediates Staphylococcus aureus Adhesion in Vaginal Epithelial Cells via Estrogen Receptor α-Associated Signaling Pathway.

Yan L, Rui C, Zhuang B, Liu X, Luan T, Jiang L Curr Microbiol. 2023; 80(12):391.

PMID: 37884702 DOI: 10.1007/s00284-023-03488-6.


Combinatorial treatments of tamoxifen and SM6Met, an extract from Vogel, are superior to either treatment alone in MCF-7 cells.

van Dyk L, Verhoog N, Louw A Front Pharmacol. 2022; 13:1017690.

PMID: 36210845 PMC: 9535530. DOI: 10.3389/fphar.2022.1017690.


Podocalyxin promotes an impermeable epithelium and inhibits pro-implantation factors to negatively regulate endometrial receptivity.

Heng S, Samarajeewa N, Wang Y, Paule S, Breen J, Nie G Sci Rep. 2021; 11(1):24016.

PMID: 34907278 PMC: 8671585. DOI: 10.1038/s41598-021-03425-2.